GKOS — Glaukos Corp

Ownership history in Campbell & CO Investment Adviser LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Campbell & CO Investment Adviser LLC reported a position in Glaukos Corp (GKOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.31% (2021 Q3)
Avg. % of fund
0.13%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,588 -289 -2.1% 0.08% $1.1M $81.55
2025 Q1 ADDED 13,877 +6,566 +89.8% 0.10% $1.4M $98.42
2024 Q4 REDUCED 7,311 -14,042 -65.8% 0.08% $1.1M $149.94
2023 Q4 ADDED 21,353 +16,154 +310.7% 0.15% $1.7M $79.49
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GKOS price (monthly, adj. close)

Other funds also holding GKOS

As of 2025 Q4 — sorted by position size

BRAIDWELL LP 3Y 3.33% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 3.02% PFM Health Sciences, LP 3Y 7Y 2.27% Rhenman & Partners Asset Management AB 3Y 7Y 2.22% Resolute Capital Asset Partners LLC 3Y 2.21% Integral Health Asset Management, LLC 3Y 1.82% Exome Asset Management LLC 1.7% Capricorn Fund Managers Ltd 3Y 1.63% Taylor Frigon Capital Management LLC 3Y 7Y 1.62% Sofinnova Investments, Inc. 3Y 7Y 1.4%
← Back to Campbell & CO Investment Adviser LLC Holdings